Do Calcium Antagonists Have a Place in the Treatment of Mood Disorders?
- 1 November 1991
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 42 (5) , 721-729
- https://doi.org/10.2165/00003495-199142050-00001
Abstract
No abstract availableThis publication has 66 references indexed in Scilit:
- Antidopaminergic action of verapamil and several other drugs: Inactivation of vesicular dopamineLife Sciences, 1990
- VerapamilDrugs, 1989
- Verapamil and Lithium in Maintenance Therapy of Manic PatientsThe Journal of Clinical Pharmacology, 1987
- Neurotoxicity Caused by Lithium‐Verapamil SynergismThe Journal of Clinical Pharmacology, 1986
- In vivo effects of the Ca2+-antagonist nimodipine on dopamine metabolism in mouse brainJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1986
- Pharmacopsychological Effects of Flunarizine in Geriatric Patients with Light Brainorganic PsychosyndromeEuropean Neurology, 1986
- Role of Calcium Entry Blockers in the Prophylaxis of MigraineEuropean Neurology, 1986
- Calcium-Antagonist DrugsNew England Journal of Medicine, 1985
- Comparison of Antimanic Efficacy of Clonidine and VerapamilThe Journal of Clinical Pharmacology, 1985
- Effect of Verapamil on the Transmural Energy Metabolism in the Isoproterenol-induced Myocardial LesionJapanese Heart Journal, 1978